Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01411332 · ClinicalTrials.gov registry record · NA
Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial
A NA study, sponsored by University of Miami.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT01411332 is a NA study that has completed, run by University of Miami. The registered enrollment target is 18 participants.
The verdict
NCT01411332, a NA study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
1. Delivery of directed hypofractionated targeted (HT) radiotherapy (RT) tumor boost to the dominant tumor lesion in the prostate as identified by multiparametric MRI will increase tumor eradication from the prostate. 2. Biomarker expression levels differ in the multiparametric MRI defined regions at high risk of harboring tumors that determine outcome. 3. 10-15% of men undergoing RT have Circulating DNA or tumor cells (CTC) that are related to an adverse treatment outcome. 4. Quality of life will not differ significantly between the treatment arms. 5. Prostate cancer-related anxiety will be reduced in the HTIMRT arm, because the patients will be aware that the dominant tumor will be targeted with higher radiation dose.
Interventions
- RADIATION SIMRT
- RADIATION HTIMRT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2011-10-31 |
| Est. Completion | 2021-11-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01411332
The ClinicalTrials.gov registry entry for NCT01411332 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which SIMRT is the first listed.
NCT01411332 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01411332 about?
NCT01411332 is a clinical study titled "Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial". 1. Delivery of directed hypofractionated targeted (HT) radiotherapy (RT) tumor boost to the dominant tumor lesion in the prostate as identified by multiparametric MRI will increase tumor eradication from the prostate. 2. Biomarker expression levels differ in the multiparametric MRI defined regions a...
What is the current status of trial NCT01411332?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2011-10-31. Estimated completion is 2021-11-22.
What interventions are being tested in trial NCT01411332?
The interventions under investigation include: SIMRT (RADIATION), HTIMRT (RADIATION).
Who is sponsoring clinical trial NCT01411332?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.